Danaher (DHR) Akcie Kurz

Danaher Corp is primarily active in the industrial and healthcare sectors.

The main competitors of Danaher Corp in the market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., and PerkinElmer, Inc.

Danaher Corp, founded in 1969, is a globally recognized company specializing in science and technology solutions. Initially an environmental testing equipment manufacturer, it has since diversified its portfolio into healthcare, industrial, and consumer sectors. With a strong emphasis on innovation, Danaher has continually expanded through strategic acquisitions, fostering growth and enhancing its capabilities. The company's commitment to operational excellence has earned it a reputation for delivering high-quality products and services across its various business segments. Over the years, Danaher Corp has established itself as a leading force in the global market, driving advancements in diagnostics, life sciences, dental care, and water quality.

Danaher Corp has achieved several significant milestones throughout its history. The company's successful acquisition of various businesses and subsequent integration has greatly expanded its product portfolio and global presence. In 1984, Danaher implemented the highly regarded Danaher Business System (DBS), a continuous improvement methodology that has driven operational excellence across its businesses. In 2016, the company completed the acquisition of Pall Corporation, a global leader in filtration, separation, and purification technologies, further strengthening its position in the life sciences and diagnostics market. The following year, Danaher completed the spin-off of its industrial business into Fortive Corporation, allowing both entities to focus on their respective growth opportunities. These milestones reflect Danaher Corp's commitment to strategic growth and delivering value to its shareholders.

Danaher Corp is primarily present in multiple countries and regions worldwide. As a multinational conglomerate, the company has a wide geographic footprint. Danaher Corp operates across various countries, including the United States, Canada, Mexico, Brazil, Argentina, Chile, Germany, France, the United Kingdom, Spain, Italy, Russia, China, Japan, India, Australia, and many more. With its global presence, Danaher Corp has established itself as a leading player in multiple industries, including life sciences, diagnostics, dental, and environmental and applied solutions.

Danaher Corp is a leading global science and technology innovator committed to improving the quality of life. The company's corporate philosophy revolves around continuous improvement and leveraging their strong portfolio of businesses to drive growth and create long-term value for shareholders. With a focus on innovation, Danaher Corp places high importance on developing cutting-edge solutions across various industries, including diagnostics, life sciences, dental, environmental, and industrial markets. By emphasizing customer-centricity and operational excellence, Danaher Corp aims to provide superior products and services that address critical challenges and improve outcomes for customers worldwide.

Analysts currently set an average price target of 221,58 USD for the Danaher stock (median: 225,00 USD), implying +10,6 % versus the latest price. The consensus is based on 32 analyst ratings.

Danaher Cílové ceny analytiků 2026

32 analysts currently rate the Danaher stock: 27 recommend buying, 5 holding and 0 selling. For 2026, analysts expect Danaher to generate revenue of 26,34 Mld. USD and earnings per share of 8,57 USD.

Danaher Cílové ceny analytiků 2026

Converted at the current exchange rate, the Danaher share trades at 175,95 EUR (203,25 USD).

The Danaher share (DHR) is listed on 10 stock exchanges, including: NYSE (DHR), London (0R2B.L), SIX (Zürich) (DHR.SW), XETRA (DAP.DE), Frankfurt (DAP.F), München (DAP.MU), Düsseldorf (DAP.DU), Wien (DHRC.VI).

The Danaher Corporation is a diversified business model with a portfolio of strategically aligned business sectors. The company develops, manufactures, and sells a variety of precision instruments and systems, as well as products and services for various applications in healthcare, environment, industry, and technology research. The key business sectors include Life Sciences, Diagnostics, Dental, Environmental & Applied Solutions, Agilent Technologies, and Pall Corporation. These divisions offer a wide range of products and services, such as medical diagnostic systems, dental instruments, environmental and water analysis devices, laboratory technologies, tools and materials for electronics manufacturing, as well as consumables and accessories for the life sciences field. Danaher also has a broad range of brands, including Cepheid, Leica Microsystems, Beckman Coulter, Hach, Esko, KaVo Kerr, ChemTreat, IDBS, Keithley, and Tektronix. These brands are leaders in their respective industries, with strong market positions and established customer bases. An important part of Danaher's business model is its management system, based on the Danaher Business System (DBS). This is a process of continuous improvement that enhances the company's efficiency and productivity. DBS is a combination of Lean Manufacturing, Six Sigma, and other innovation techniques, and has proven successful in streamlining business processes, reducing costs, and improving overall company performance. The company also has a strong global presence, with an extensive network of sales and service centers in North America, Europe, Asia, and other regions worldwide. Danaher generates a significant portion of its revenue outside the US and benefits from growing demand in emerging markets. The company also invests in research and development to develop innovative products and solutions that meet the needs of its customers. Overall, Danaher's business model is well-positioned for success in various industries and on a global scale, thanks to its diversified product range, brands, and management process. The company has proven itself by providing tailored solutions to meet its customers' needs and consistently executing its growth strategies.

Tržby očekávané za Danaher činí 26,34 Mld. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.

Zisk očekávané za Danaher činí 6,09 Mld. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.

Poměr ceny k zisku (P/E) Danaher je aktuálně 23,73. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Danaher.

Poměr ceny k tržbám (P/S) Danaher je aktuálně 5,49. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Danaher.

Score kvality pro Danaher je 5/10.

ISIN Danaher je US2358511028. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.

WKN Danaher je 866197. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.

Ticker Danaher je DHR. Symbol tickeru se používá k obchodování akcií Danaher na burze.

Během posledních 12 měsíců zaplatila Danaher dividendu v částce 1,28 USD . To odpovídá dividendovému výnosu přibližně 0,63 %. Pro nadcházejících 12 měsíců se očekává, že Danaher zaplatí dividendu 1,80 USD.

Dividendová výtěžnost Danaher je v současné době 0,63 %.

Danaher vyplací dividendu rozdělenou v měsících září, prosinec, březen, červen.

Danaher vyplácela dividendu každý rok během posledních 33 let.

Pro nadcházejících 12 měsíců se očekávají dividendy ve výši 1,80 USD. To odpovídá dividendovému výnosu 0,90 %.

Danaher je přiřazena sektoru 'Zdravotnictví'.

V roce 2025 byla Danaher vyplacena dividenda ve výši 1,28 USD.

Dividendy Danaher jsou vypláceny v USD.